News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
92,175 Results
Type
Article (2892)
Company Profile (6)
Press Release (89277)
Section
Business (25447)
Career Advice (518)
Deals (5814)
Drug Delivery (4)
Drug Development (13135)
Employer Resources (28)
FDA (1787)
Job Trends (1768)
News (45864)
Policy (3830)
Tag
Academia (223)
Accelerated approval (8)
Adcomms (2)
Allergies (31)
Alliances (4690)
ALS (40)
Alzheimer's disease (396)
Antibody-drug conjugate (ADC) (31)
Approvals (1863)
Artificial intelligence (81)
Autoimmune disease (37)
Automation (2)
Bankruptcy (71)
Best Places to Work (1620)
BIOSECURE Act (2)
Biosimilars (37)
Biotechnology (4)
Bladder cancer (69)
Brain cancer (14)
Breast cancer (62)
Cancer (925)
Cardiovascular disease (50)
Career advice (419)
Career pathing (3)
CAR-T (36)
CDC (17)
Celiac Disease (1)
Cell therapy (147)
Cervical cancer (5)
Clinical research (11982)
Collaboration (254)
Compensation (90)
Complete response letters (8)
COVID-19 (307)
CRISPR (13)
C-suite (155)
Cystic fibrosis (11)
Data (1608)
Decentralized trials (1)
Denatured (10)
Depression (34)
Diabetes (76)
Diagnostics (957)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (8)
Drug discovery (31)
Drug pricing (28)
Drug shortages (1)
Duchenne muscular dystrophy (41)
Earnings (15354)
Editorial (15)
Employer branding (4)
Employer resources (29)
Events (16344)
Executive appointments (167)
FDA (2545)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (191)
Gene editing (32)
Generative AI (5)
Gene therapy (97)
GLP-1 (127)
Government (460)
Guidances (145)
Healthcare (2504)
HIV (8)
Huntington's disease (2)
IgA nephropathy (21)
Immunology and inflammation (26)
Immuno-oncology (11)
Indications (18)
Infectious disease (360)
Inflammatory bowel disease (35)
Inflation Reduction Act (2)
Influenza (33)
Intellectual property (83)
Interviews (123)
IPO (3727)
IRA (1)
Job creations (220)
Job search strategy (338)
JPM (19)
Kidney cancer (7)
Labor market (6)
Layoffs (28)
Leadership (10)
Legal (724)
Liver cancer (18)
Longevity (1)
Lung cancer (134)
Lymphoma (81)
Machine learning (9)
Management (12)
Manufacturing (102)
MASH (64)
Medical device (1981)
Medtech (2000)
Mergers & acquisitions (2435)
Metabolic disorders (229)
Multiple sclerosis (41)
NASH (7)
Neurodegenerative disease (62)
Neuropsychiatric disorders (22)
Neuroscience (687)
NextGen: Class of 2026 (658)
Non-profit (393)
Obesity (83)
Opinion (31)
Ovarian cancer (24)
Pain (43)
Pancreatic cancer (81)
Parkinson's disease (60)
Partnered (2)
Patents (167)
Patient recruitment (97)
Peanut (14)
People (7083)
Pharmaceutical (1)
Pharmacy benefit managers (4)
Phase 1 (3898)
Phase 2 (5542)
Phase 3 (3709)
Pipeline (1503)
Policy (69)
Postmarket research (209)
Preclinical (1507)
Press Release (3)
Prostate cancer (47)
Psychedelics (6)
Radiopharmaceuticals (48)
Rare diseases (176)
Real estate (379)
Recruiting (12)
Regulatory (3506)
Reports (5)
Research institute (190)
Resumes & cover letters (83)
Rett syndrome (18)
RNA editing (1)
RSV (12)
Schizophrenia (52)
Series A (15)
Series B (12)
Sickle cell disease (16)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (2)
Startups (164)
Supply chain (20)
Tariffs (20)
The Weekly (27)
Vaccines (166)
Venture capital (14)
Weight loss (38)
Women's health (11)
Worklife (3)
Date
Last 7 days (86)
Last 30 days (404)
Last 365 days (6824)
2026 (579)
2025 (6898)
2024 (7791)
2023 (9107)
2022 (9212)
2021 (9651)
2020 (8809)
2019 (5895)
2018 (4109)
2017 (4345)
2016 (3313)
2015 (4408)
2014 (2694)
2013 (1860)
2012 (2016)
2011 (2114)
2010 (1844)
Location
Africa (110)
Alabama (17)
Arizona (16)
Arkansas (1)
Asia (4765)
Australia (729)
California (2889)
Canada (656)
China (140)
Colorado (92)
Connecticut (115)
Delaware (38)
Europe (9539)
Florida (314)
Georgia (78)
Idaho (1)
Illinois (167)
India (6)
Indiana (86)
Japan (62)
Kansas (58)
Kentucky (3)
Maine (5)
Maryland (323)
Massachusetts (1769)
Michigan (53)
Minnesota (108)
Missouri (5)
Montana (1)
Nebraska (5)
Nevada (19)
New Hampshire (19)
New Jersey (938)
New York (987)
North Carolina (189)
Northern California (1322)
Ohio (26)
Oregon (2)
Pennsylvania (647)
Rhode Island (8)
South America (172)
South Carolina (3)
Southern California (1222)
Tennessee (57)
Texas (509)
United States (9604)
Utah (24)
Virginia (85)
Washington D.C. (20)
Washington State (191)
Wisconsin (3)
92,175 Results for "autism speaks".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
A New Era in Early Autism Support: LinusBio and Autism Speaks Partner to Promote Earlier Autism Diagnosis and Intervention
April 17, 2025
·
5 min read
Press Releases
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
January 14, 2026
·
8 min read
Editorial
Kennedy’s Hunt for a Connection Between Vaccines and Autism Is a Sham
The Health and Human Services Secretary said that he will find and eliminate the cause of autism by September, an idea that suggests how little he knows about the condition.
April 17, 2025
·
3 min read
·
Dan Samorodnitsky
Press Releases
Yamo Pharma Presents Statistically Significant Phase 2 Autism Results for L1-79 at INSAR 2025
Trial achieves unprecedented and clinically meaningful socialization gains in adolescents and young adults, addressing core autism symptoms currently lacking FDA-approved therapies.
May 8, 2025
·
1 min read
Press Releases
Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis and Treatment of Autism Spectrum Disorder
November 5, 2025
·
6 min read
Press Releases
Rosalind Franklin University Secures $1.7M in NIH Funding to Advance Research on Social Recognition Mechanisms in Schizophrenia and Autism Spectrum Disorders
December 19, 2025
·
1 min read
Government
FDA Revives Decades-Dormant Drug as Potential Autism Treatment
The agency also pointed to the use of Tylenol and other acetaminophen products during pregnancy as being potentially linked to neurological and developmental defects in children, following a press conference Monday in which President Donald Trump did the same.
September 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Feinstein Institutes’ Scientists Find Common Blood Pressure Drug Could Be Beneficial in Some Cases of Autism
October 27, 2025
·
3 min read
Press Releases
Artisan Therapeutics and Tulex Pharmaceuticals Announce Positive Phase 2a Results for ART-501, a Novel Oral Liquid Extended-Release Formulation for Autism Spectrum Disorder
November 18, 2025
·
4 min read
Podcast
FDA’s Autism Endeavor, Pfizer’s Obesity Comeback Bid, Psychedelics Revival, ACIP Confusion, More
The FDA is hoping to repurpose GSK’s Wellcovorin for cerebral folate deficiency; Pfizer acquired fast-moving weight-loss startup Metsera for nearly $5 billion after suffering a hat trick of R&D failures; psychedelics are primed for M&A action and Eli Lilly may be next in line; RFK Jr.’s revamped CDC advisory committee met last week with confounding results; and Stealth secured its Barth approval.
September 24, 2025
·
2 min read
·
Heather McKenzie
1 of 9,218
Next